Commentary
2021-02-22
小米澄清「造車」傳聞 留意20926購/69159熊
上周五(19日)港股先跌後升下全日拗腰倒升50點收市,本周多隻重磅股陸續「放榜」,投資者看好可留意新上市恆指牛證66403,收回價30400點,換股比率10000:1。相反看淡亦可留意恆指熊證63502,收回價31300點,實際槓桿31.59倍,換股比率10000:1。
 
小米集團(1810)上周五午後傳出集團有意發展電動車消息,尾市最多曾急升逾一成重上32元水平,收市時升幅收窄仍錄得逾半成升幅。惟集團發表公告澄清公司並未就就相關業務正式設立發展方向。投資者如看好可留意購證20926,行使價33.85元,實際槓桿5.6倍,21年5月到期。相反看淡亦可留意熊證69159,收回價33.5元,實際槓桿11.79倍,換股比率50:1。
 
市場關注匯豐控股(0005)獲准恢復派息後首份「成績表」,集團將於明日公佈去年業績及派息安排。續看好可留意購證19944,行使價52.93元,實際槓桿9.19倍,21年6月到期。相反看淡亦可留意沽證15048,行使價39.34元,實際槓桿7.27倍,21年5月到期。
 
另一大型藍籌港交所(0388)亦將於周三公布末期業績。輪證資金上日有逾2060萬元淨流入其好倉部署,投資者如看好可留意新上市牛證66438,收回價555.8元,換股比率500:1,相反看淡亦可留意同為新上市熊證66475,收回價595元,換股比率500:1。
The information on this material is provided and published by Haitong International Securities Company Limited (“HTI”), a corporation holding licences for Type 1 (dealing in securities) and Type 4 (advising in securities) regulated activities pursuant to the Securities and Futures Ordinance (Cap. 571). The contents of this material has not been reviewed or approved by the Securities and Futures Commission. Any and all information provided on this material is for reference only and does not constitute an offer, a solicitation of an offer or any advice or recommendation to buy or sell any financial products. The prices of structured products such as Warrants and/or CBBCs may fluctuate greatly and past performance is not indicative of future performance. The value of structured products may become zero on or before the expiry date and investors may sustain a total loss of investment. CBBCs have a mandatory call feature and are subject to early termination, upon which (i) investors in category N CBBCs will lose all their investments in CBBCs; and (ii) the residual value of category R CCBCs may be zero. Structured products issued by HTI or its affiliate are uncollateralised and investors are relying on the issuer’s credit worthiness in determining the issuer’s ability to meet its obligations under the structured products. If the Issuer is insolvent or defaults in payment, investors may not recover part or all of the amount due. An investor should read carefully the relevant listing documents (and any documents appendix thereto) and the relevant supplemental listing document to understand the full details of the warrant and/or CBBC (including risk factors), and due consideration have been given having considered the nature and risks involved in investing in these products, to decide whether the investment is suitable for an investor’s individual circumstances and, if necessary, an investor should consult their professional advisers. HTI is also the liquidity provider for the warrants and/or CBBCs (“Structured Products”) referred to in the material . HTI may be the only person quoting prices (or market making) for the Structured Products on the exchange. As such, the secondary market for the Structured Products may be limited. HTI (together with its subsidiaries and affiliates, “HTI Group”) provides the information in good faith and has used its best endeavours to ensure that the information provided is accurate and complete. HTI Group however does not represent or warrant the completeness or accuracy of the information and HTI Group. Haitong International Securities Company Limited may make a market in the securities and/ or the derivatives on these securities herein covered. Haitong International Securities Company Limited and/or its group company(ies) may have presently, or have had within the last 12 months, an investment banking relationship with the underlying entity of the securities herein covered. Haitong International Securities Company Limited is a member of Haitong International Securities Group which in turn belongs to group of companies of Haitong Securities Co., Ltd. HTISG and our affiliates, officers, directors, and employees, excluding the analysts responsible for the content of this document, will from time to time have long or short positions in, act as principal in, and buy or sell, the securities or derivatives, if any, referred to in this document. Haitong International Securities Company Limited and/or its group company(ies) and its affiliates, officers, directors, and employees, excluding the analysts responsible for the content of this document, will from time to time have long or short positions in, act as principal in, and buy or sell, the securities or derivatives, if any, referred to in this document.